Raphael Pharmaceutical Inc. (RAPH)

OTCMKTS · Delayed Price · Currency is USD
1.400
0.00 (0.00%)
At close: Jan 20, 2026
40.00%
Market Cap 28.25M
Revenue (ttm) n/a
Net Income (ttm) -1.40M
Shares Out 20.18M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 111
Average Volume 516
Open 1.400
Previous Close 1.400
Day's Range 1.400 - 1.400
52-Week Range 0.040 - 1.400
Beta 2.70
RSI 53.39
Earnings Date Mar 27, 2026

About Raphael Pharmaceutical

Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. The company is headquartered in Tel Aviv-Jaffa, Israel. [Read more]

Sector Healthcare
CEO Shlomo Pilo
Country United States
Stock Exchange OTCMKTS
Ticker Symbol RAPH
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.